This content is only available as a PDF.
Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Article PDF first page preview

First page of Estimation of Benefit to Bispecific Antibodies in US Patients with Lymphoma and Multiple Myeloma

Supplemental data